PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-6.14%
Revenue decline while JHX shows 0.00% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-6.14%
Gross profit decline while JHX shows 0.00% growth. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses change of 100.00% while JHX maintains costs. Bruce Berkowitz would investigate efficiency.
100.00%
Operating expenses change of 100.00% while JHX maintains costs. Bruce Berkowitz would investigate control.
100.00%
Total costs change of 100.00% while JHX maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.30%
EBITDA change of 133.30% while JHX is flat. Bruce Berkowitz would examine quality.
135.48%
Margin change of 135.48% while JHX is flat. Bruce Berkowitz would examine quality.
133.30%
Income change of 133.30% while JHX is flat. Bruce Berkowitz would examine quality.
135.48%
Margin change of 135.48% while JHX is flat. Bruce Berkowitz would examine quality.
-100.00%
Other expenses reduction while JHX shows 0.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.95%
Tax expense change of 64.95% while JHX maintains burden. Bruce Berkowitz would investigate strategy.
-64.95%
Net income decline while JHX shows 0.00% growth. Joel Greenblatt would examine position.
-62.66%
Net margin decline while JHX shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.